Eva Santermans

821 total citations
27 papers, 492 citations indexed

About

Eva Santermans is a scholar working on Pulmonary and Respiratory Medicine, Modeling and Simulation and Developmental Neuroscience. According to data from OpenAlex, Eva Santermans has authored 27 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Modeling and Simulation and 5 papers in Developmental Neuroscience. Recurrent topics in Eva Santermans's work include COVID-19 epidemiological studies (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Eva Santermans is often cited by papers focused on COVID-19 epidemiological studies (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Eva Santermans collaborates with scholars based in Belgium, United States and United Kingdom. Eva Santermans's co-authors include Niel Hens, Philippe Beutels, Jan P. van Meerbeeck, Jonas R.M. Van Audenaerde, Evelien Smits, Jorrit De Waele, Elly Marcq, Patrick Pauwels, Christel Faes and Herman Goossens and has published in prestigious journals such as Blood, PLoS ONE and Proceedings of the Royal Society B Biological Sciences.

In The Last Decade

Eva Santermans

26 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Santermans Belgium	13	126	118	83	78	66	27	492
Degang Wu China	13	83 0.7×	229 1.9×	116 1.4×	27 0.3×	35 0.5×	39	985
Matthew K. Stein United States	13	123 1.0×	26 0.2×	89 1.1×	136 1.7×	39 0.6×	23	516
Julie McLeod United Kingdom	17	16 0.1×	22 0.2×	50 0.6×	86 1.1×	289 4.4×	42	656
Ning Tu China	12	130 1.0×	26 0.2×	44 0.5×	122 1.6×	10 0.2×	26	469
Daniel Sánchez‐Taltavull Switzerland	12	39 0.3×	36 0.3×	72 0.9×	38 0.5×	56 0.8×	32	567
Luchino Chessa Italy	15	63 0.5×	14 0.1×	479 5.8×	54 0.7×	90 1.4×	70	1.0k
Ilker Tunc United States	14	28 0.2×	15 0.1×	82 1.0×	59 0.8×	45 0.7×	35	645
H. Lepetit France	10	201 1.6×	7 0.1×	116 1.4×	58 0.7×	7 0.1×	17	703
Olivier Heinzlef France	10	30 0.2×	6 0.1×	47 0.6×	110 1.4×	41 0.6×	25	604
Genay Pilarowski United States	11	19 0.2×	25 0.2×	22 0.3×	57 0.7×	104 1.6×	14	468

Countries citing papers authored by Eva Santermans

Since Specialization

Citations

This map shows the geographic impact of Eva Santermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Santermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Santermans more than expected).

Fields of papers citing papers by Eva Santermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Santermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Santermans. The network helps show where Eva Santermans may publish in the future.

Co-authorship network of co-authors of Eva Santermans

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Santermans. A scholar is included among the top collaborators of Eva Santermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Santermans. Eva Santermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kersten, Marie José, Évelyne Willems, Marte C. Liefaard, et al.. (2024). Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma. Blood. 144(Supplement 1). 93–93. 1 indexed citations

Vermeire, Séverine, Stefan Schreiber, David T. Rubin, et al.. (2024). Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial. The Lancet. Gastroenterology & hepatology. 10(2). 138–153. 2 indexed citations

Dotan, Iris, Brian G. Feagan, Alessandra Oortwijn, et al.. (2023). Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial. Journal of Crohn s and Colitis. 17(8). 1207–1216. 7 indexed citations

Strâmbu, Irina, Christian A. Seemayer, Paul A. Ford, et al.. (2022). GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial. European Respiratory Journal. 61(3). 2201794–2201794. 27 indexed citations

Abrams, Steven, James Wambua, Eva Santermans, et al.. (2021). Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories. Epidemics. 35. 100449–100449. 50 indexed citations

Cottin, Vincent, Christian A. Seemayer, Paul Ford, et al.. (2021). Results of a phase 2 study of GLPG1205 for idiopathic pulmonary fibrosis (PINTA). RCT2904–RCT2904. 2 indexed citations

Koningsbruggen‐Rietschel, Silke van, Katja Conrath, Rainald Fischer, et al.. (2019). GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN). Journal of Cystic Fibrosis. 19(2). 292–298. 10 indexed citations

Santermans, Eva, et al.. (2019). Overcoming the challenges of iris scanning to identify minors (1–4 years) in the real-world setting. BMC Research Notes. 12(1). 448–448. 7 indexed citations

Santermans, Eva, Paul Ford, Michael Kreuter, et al.. (2019). Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design. Advances in Therapy. 36(11). 3059–3070. 5 indexed citations

10.

Marcq, Elly, Jorrit De Waele, Jonas R.M. Van Audenaerde, et al.. (2017). Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients. Oncotarget. 8(52). 89722–89735. 45 indexed citations

11.

Santermans, Eva, Kim Van Kerckhove, W. John Edmunds, et al.. (2016). Structural differences in mixing behavior informing the role of asymptomatic infection and testing symptom heritability. Mathematical Biosciences. 285. 43–54. 9 indexed citations

12.

Bertoglio, Daniele, Jeroen Verhaeghe, Eva Santermans, et al.. (2016). Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbidities. Brain Behavior and Immunity. 61. 69–79. 33 indexed citations

13.

Santermans, Eva, Emmanuel Robesyn, Tapiwa Ganyani, et al.. (2016). Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness. PLoS ONE. 11(1). e0147172–e0147172. 31 indexed citations

14.

Blon, Debbie Le, Caroline Guglielmetti, Chloé Hoornaert, et al.. (2016). Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model. Journal of Neuroinflammation. 13(1). 288–288. 36 indexed citations

15.

Praet, Jelle, Firat Kara, Caroline Guglielmetti, et al.. (2015). Cuprizone‐induced demyelination and demyelination‐associated inflammation result in different proton magnetic resonance metabolite spectra. NMR in Biomedicine. 28(4). 505–513. 18 indexed citations

16.

Santermans, Eva, Nele Goeyvaerts, Alessia Melegaro, et al.. (2015). The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe. Epidemics. 11. 14–23. 21 indexed citations

17.

Hens, Niel, Steven Abrams, Eva Santermans, et al.. (2015). Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. Eurosurveillance. 20(1). 25 indexed citations

18.

Costa, Roberta, Irene Bergwerf, Eva Santermans, et al.. (2015). Distinct In Vitro Properties of Embryonic and Extraembryonic Fibroblast-Like Cells are Reflected in their in Vivo Behavior following Grafting in the Adult Mouse Brain. Cell Transplantation. 24(2). 223–233. 5 indexed citations

19.

Praet, Jelle, Eva Santermans, Kristien Reekmans, et al.. (2014). Histological Characterization and Quantification of Cellular Events Following Neural and Fibroblast(-Like) Stem Cell Grafting in Healthy and Demyelinated CNS Tissue. Methods in molecular biology. 1213. 265–283. 6 indexed citations

20.

Praet, Jelle, Eva Santermans, Jasmijn Daans, et al.. (2014). Early Inflammatory Responses following Cell Grafting in the CNS Trigger Activation of the Subventricular Zone: A Proposed Model of Sequential Cellular Events. Cell Transplantation. 24(8). 1481–1492. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact